COMMUNIQUÉS West-GlobeNewswire

« Réussir le test » sur la santé mentale sur les campus à la suite d’une nouvelle formation pour les étudiants du postsecondaire

01/10/2019 - 16:00

De la Commission de la santé mentale du Canada OTTAWA, 01 oct. 2019 (GLOBE NEWSWIRE) -- Aujourd’hui, la Commission de la santé mentale du Canada (CSMC), en partenariat avec l’Université de Calgary, a officiellement [...]

Novartis and Microsoft announce collaboration to transform medicine with artificial intelligence

01/10/2019 - 16:00

Multiyear alliance underpins the Novartis commitment to leverage data & Artificial Intelligence (AI) to transform how medicines are discovered, developed and commercialized Novartis to establish AI innovation lab to [...]

NOTICE TO CONVENE EXTRAORDINARY GENERAL MEETING

01/10/2019 - 15:35

INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLING KALLELSE TILL EXTRA BOLAGSSTÄMMA Der indkaldes herved til ekstraordinær generalforsamling i Oncology Venture A/S (“ Selskabet “), som afholdes: Notice is hereby given that [...]

Generex Biotechnology Subsidiary Olaregen Therapeutix Launches Excellagen Wound Conforming Matrix 3.0 cc Pre-Filled Syringe

01/10/2019 - 15:15

MIRAMAR, Fla., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation ( www.generex.com ) ( GNBT ) ( http://www.otcmarkets.com/stock/GNBT/quote ), is pleased to announce that their subsidiary, Olaregen [...]

Evolus Receives Approval for Nuceiva™ in the European Union

01/10/2019 - 15:09

NEWPORT BEACH, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a customer-centric approach focused on delivering breakthrough products, today announced that the [...]

BrainsWay Announces Innovative Deep Transcranial Magnetic Stimulation System Showcase Presentation at this Year’s Psych Congress Meeting

01/10/2019 - 15:00

JERUSALEM, Oct. 01, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ: BWAY, TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, announced today they will be hosting “Advances in [...]

Adamis Pharmaceuticals Announces Commercial Partnership with Emerge Health for SYMJEPI® in Australia and New Zealand

01/10/2019 - 15:00

SAN DIEGO, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) announced today that it has entered into an exclusive distribution and commercialization agreement with Emerge Health Pty (“ [...]

Acasti Pharma to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference

01/10/2019 - 15:00

LAVAL, Québec, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]

Sabin Vaccine Institute Receives $20.5 Million From BARDA With Potential of up to $128 Million to Develop Ebola Sudan and Marburg Vaccines

01/10/2019 - 15:00

WASHINGTON, Oct. 01, 2019 (GLOBE NEWSWIRE) -- The Sabin Vaccine Institute (Sabin) today announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and [...]

Cabaletta Bio Receives IND Clearance from FDA to Initiate First Clinical Trial of DSG3-CAART in Patients with Mucosal Pemphigus Vulgaris

01/10/2019 - 15:00

First IND clearance of a product candidate derived from the CABA™ platform PHILADELPHIA, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Company), a clinical-stage biotechnology company focused on the discovery [...]

Smile Direct Club to Report Third Quarter 2019 Financial Results on November 12, 2019

01/10/2019 - 14:52

NASHVILLE, Tenn., Oct. 01, 2019 (GLOBE NEWSWIRE) -- SmileDirectClub, Inc. (NASDAQ: SDC) (“SmileDirectClub”), the industry pioneer and first direct-to-consumer medtech platform for transforming smiles, announced today it [...]

Marrone Bio Innovations Announces Approval of Stargus® in Mexico

01/10/2019 - 14:31

DAVIS, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), an international leader in sustainable bioprotection and plant health solutions, today announced that its novel [...]

Caladrius Biosciences to Participate at the Upcoming October Conferences

01/10/2019 - 14:30

BASKING RIDGE, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company pioneering advancements [...]

PDS Biotechnology Prioritizes Development of PDS0101 in Advanced Cancers Following Promising Phase 1 Clinical Outcome Data

01/10/2019 - 14:30

Data demonstrated regression of lesions in 60% of patients BERKELEY HEIGHTS, N.J., Oct. 01, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology [...]

Agritek Holdings, Inc. Announces Agreement with Leading California Manufacturing Facility Apex Solutions Ending Third Quarter with $200,000 in New Purchase Orders

01/10/2019 - 14:30

LOS ANGELES, CA, Oct. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Agritek Holdings, Inc. (OTC: AGTK) www.AgritekHoldings.com , a fully integrated, active real estate investor for the cannabis sector and consultant [...]

REPEAT - Integrated Cannabis’ Ganja Gold takes Delivery of Fully Automated Proprietary Pre-Roll Manufacturing Machine

01/10/2019 - 14:30

VANCOUVER, British Columbia, Oct. 01, 2019 (GLOBE NEWSWIRE) -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“ Integrated Cannabis ” or the “ Company ”), a multi-state brand operator in California and [...]

Align Technology to Announce Third Quarter 2019 Results on October 23, 2019

01/10/2019 - 14:30

SAN JOSE, Calif., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Align Technology, Inc. (Nasdaq: ALGN) announced today that the Company will report third quarter 2019 financial results on Wednesday, October 23, 2019, after the close [...]

TYME Presented Updated Data at ESMO 2019 from SM-88 Phase II Prostate Cancer Study Demonstrating Encouraging Clinical Benefit in Patients with Recurrent Prostate Cancer

01/10/2019 - 14:00

Study results demonstrate that oral SM-88 may play a clinically meaningful role in postponing use of hormonal castration in prostate cancer patients with rising prostate-specific antigen (PSA): More than 450,000 of [...]

BioDelivery Sciences Announces Significant Additional Insurance Coverage for both BELBUCA® and Symproic®

01/10/2019 - 14:00

Major Pharmacy Benefit Manager (PBM) Improves Access for Both Products to Approximately 14 Million Lives Symproic Will be Listed as Preferred Exclusive and BELBUCA Preferred or Preferred Exclusive RALEIGH, N.C., Oct. 01 [...]